Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,255.40
+11.000.88%
Post-market: 1,254.06-1.3400-0.11%19:59 EDT
Volume:2.50M
Turnover:3.14B
Market Cap:1.19T
PE:42.14
High:1,271.22
Open:1,232.00
Low:1,230.00
Close:1,244.40
52wk High:1,292.65
52wk Low:694.23
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.91
T/O Rate:0.27%
Dividend:6.46
Dividend Rate:0.51%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:35.03
PE(LYR):54.70

Loading ...

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Yesterday

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Yesterday

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B

TradingKey
·
Aug 20

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

7 Growth Stocks Holding up in a Tough Market

Dow Jones
·
Aug 20

Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's (LLY) Narrative?

Simply Wall St.
·
Aug 20

Amplitude Therapeutics: Lilly to GET Exclusive, Target-Specific Rights to Develop ,Commercialize Licensed Products Directed to Collaboration Targets

THOMSON REUTERS
·
Aug 20

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying Rna Vaccines for Infectious Diseases

THOMSON REUTERS
·
Aug 20

Amplitude: Initial Programs Target Infectious Diseases with High Unmet Need, with Lilly Retaining Options for up to Two Additional Targets

THOMSON REUTERS
·
Aug 20

World's Largest Companies by Market Cap (July 2026): Nvidia Leads, AI Theme Intact but Chip Stocks Face Valuation Adjustments

TradingKey
·
Aug 20

Eli Lilly on Track for Record High Close

Dow Jones
·
Aug 20

Eli Lilly Advances Oral Pipeline With New LY4065967 Formulation Study

TIPRANKS
·
Aug 20

Eli Lilly Stock (LLY) Hits All-Time High as Post-Earnings Rally Continues

TIPRANKS
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|Eli Lilly Rises 3.49% in Regular Trading, S&P 500 Healthcare Sector Hits All-Time High Amid Multiple Pipeline Catalysts

Market Focus
·
Aug 19

Novo Begins Study to Find Lowest Effective Dose for Wegovy Pill

Reuters
·
Aug 19

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19